《大行報告》摩通削瑞聲(02018.HK)次季每股盈測47% 評級維持「中性」
摩根大通發表報告指,Android智能手機於今年第二季的銷售出貨按季下跌約15%,料將繼續拖累瑞聲科技(02018.HK)的毛利率改善。因此,該行將集團次季每股盈利預測下調47%,較市場預期低56%。
展望今年下半年,雖然Android智能手機的能見度仍低,但摩通估計「iPhone 14」的新產品周期仍會是主要催化劑。另外,即使瑞聲正與主要客戶改善產品供應和市場佔有率,並成為整體解決方案提供商,但該行認為終端市場的拐點尚未到來。
摩通維持對瑞聲股份「中性」評級及目標價18元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.